GeneDx Holdings Corp. Quarterly Debt-to-equity in % from Q2 2021 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GeneDx Holdings Corp. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q4 2024.
  • GeneDx Holdings Corp. Debt-to-equity for the quarter ending December 31, 2024 was 89.4 %, a 31.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 89.4 +21.6 +31.8% Dec 31, 2024
Q3 2024 93.2 +22.8 +32.4% Sep 30, 2024
Q2 2024 83.3 +20.7 +33% Jun 30, 2024
Q1 2024 73.2 +16 +28.1% Mar 31, 2024
Q4 2023 67.8 +12.3 +22.2% Dec 31, 2023
Q3 2023 70.4 +22.5 +47% Sep 30, 2023
Q2 2023 62.7 +13.3 +26.8% Jun 30, 2023
Q1 2023 57.2 -123 -68.2% Mar 31, 2023
Q4 2022 55.5 +441 Dec 31, 2022
Q3 2022 47.9 +172 Sep 30, 2022
Q2 2022 49.4 +116 Jun 30, 2022
Q1 2022 180 Mar 31, 2022
Q4 2021 -386 Dec 31, 2021
Q3 2021 -124 Sep 30, 2021
Q2 2021 -66.4 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.